{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T06:42:19Z","timestamp":1773384139705,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.dsx.2018.11.058","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T03:25:10Z","timestamp":1543980310000},"page":"764-768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Plasma endoglin in Type2 diabetic patients with nephropathy"],"prefix":"10.1016","volume":"13","author":[{"given":"Ahmed S.","family":"Doghish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atef A.","family":"Bassyouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed H.","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heba G.","family":"Abd El-Aziz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania Y.","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dsx.2018.11.058_bib1","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4093\/dmj.2014.38.2.109","article-title":"Prevalence and determinants of diabetic nephropathy in korea: korea national health and nutrition examination survey","volume":"38","author":"Ahn","year":"2014","journal-title":"Diabetes Metab J"},{"issue":"1","key":"10.1016\/j.dsx.2018.11.058_bib2","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2012.11.031","article-title":"US renal data system 2012 annual data report","volume":"61","author":"Collins","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.dsx.2018.11.058_bib3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1053\/j.ajkd.2014.08.001","article-title":"Diabetic kidney disease: a report from an ADA consensus & conference","volume":"64","author":"Tuttle","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.dsx.2018.11.058_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mpmed.2014.10.007","article-title":"Diabetic nephropathy","volume":"43","author":"Thomas","year":"2015","journal-title":"Medicine"},{"issue":"24","key":"10.1016\/j.dsx.2018.11.058_bib5","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2011.861","article-title":"Temporal trends in the prevalence of diabetic kidney disease in the United States","volume":"305","author":"de Boer","year":"2011","journal-title":"J\u00a0Am Med Assoc"},{"issue":"1","key":"10.1016\/j.dsx.2018.11.058_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/kisup.2012.65","article-title":"Chapter 2: definition, identification, and prediction of CKD progression","volume":"3","author":"KDIGO","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"10.1016\/j.dsx.2018.11.058_bib7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","article-title":"KDOQI clinical practice guideline for diabetes and CKD: 2012 update","volume":"60","author":"National Kidney Foundation","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.dsx.2018.11.058_bib8","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1172\/JCI72271","article-title":"Molecular mechanisms of diabetic kidney disease","volume":"124","author":"Reidy","year":"2014","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.dsx.2018.11.058_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bbrc.2013.02.120","article-title":"Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy","volume":"433","author":"Sun","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.dsx.2018.11.058_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2015.10.003","article-title":"Soluble endoglin, hypercholesterolemia and endothelial dysfunction","volume":"243","author":"Rathouska","year":"2015","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.dsx.2018.11.058_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jsps.2013.04.005","article-title":"Therapeutic approaches to drug targets in atherosclerosis","volume":"22","author":"Jamkhande","year":"2014","journal-title":"Saudi Pharmaceut J"},{"key":"10.1016\/j.dsx.2018.11.058_bib12","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/BF01506150","article-title":"Enzymatic determination of glucose and fructose simultaneously","volume":"39","author":"Schmidt","year":"1961","journal-title":"Klin Wochenschr"},{"issue":"6","key":"10.1016\/j.dsx.2018.11.058_bib13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198402093100602","article-title":"The clinical information value of the glycosylated hemoglobin assay","volume":"310","author":"Nathan","year":"1984","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.dsx.2018.11.058_bib14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/clinchem\/20.4.470","article-title":"Enzymatic determination of total serum cholesterol","volume":"20","author":"Allain","year":"1974","journal-title":"Clin Chem"},{"issue":"8","key":"10.1016\/j.dsx.2018.11.058_bib15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/clinchem\/17.8.696","article-title":"Automated reaction-rate method for determination of serum creatinine with the CentrifiChem","volume":"17","author":"Fabiny","year":"1971","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.dsx.2018.11.058_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"issue":"2\u20133","key":"10.1016\/j.dsx.2018.11.058_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0009-8981(85)90341-9","article-title":"Rapid and sensitive immunoassay for albumin determination in urine","volume":"149","author":"Harmoinen","year":"1985","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.dsx.2018.11.058_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1399-0039.1997.tb02870.x","article-title":"Mapping epitopes to distinct regions of the extracellular domain of endoglin using bacterially expressed recombinant fragments","volume":"50","author":"Pichuantes","year":"1997","journal-title":"Tissue Antigens"},{"issue":"8","key":"10.1016\/j.dsx.2018.11.058_bib19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jama.2015.0602","article-title":"Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review","volume":"313","author":"Levey","year":"2015","journal-title":"J\u00a0Am Med Assoc"},{"issue":"2","key":"10.1016\/j.dsx.2018.11.058_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.numecd.2009.02.013","article-title":"Obesity and changes in urine albumin\/creatinine ratio in patients with type 2 diabetes: the DEMAND Study","volume":"20","author":"Rossi","year":"2010","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.dsx.2018.11.058_bib21","first-page":"8","article-title":"Study of dyslipidemia and cystatin C levels as a predictive marker of chronic kidney disease in type 2 diabetes mellitus patients at a teaching hospital in Central India","volume":"3","author":"Kachhawa","year":"2016","journal-title":"J\u00a0of Integr Nephrol Androl"},{"issue":"1","key":"10.1016\/j.dsx.2018.11.058_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41100-016-0028-0","article-title":"Dyslipidemia in diabetic nephropathy","volume":"2","author":"Kawanami","year":"2016","journal-title":"Ren Replace Ther"},{"issue":"60","key":"10.1016\/j.dsx.2018.11.058_bib23","doi-asserted-by":"crossref","first-page":"102550","DOI":"10.18632\/oncotarget.21684","article-title":"A\u00a0non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"issue":"36","key":"10.1016\/j.dsx.2018.11.058_bib24","first-page":"2526","article-title":"Metabolic syndrome and microalbuminuria accompanied with hyperglycemia in community subjects","volume":"92","author":"Wang","year":"2012","journal-title":"Zhonghua Yixue Zazhi"},{"issue":"9731","key":"10.1016\/j.dsx.2018.11.058_bib25","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality: a collaborative meta-analysis of general population cohorts","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.dsx.2018.11.058_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1681\/ASN.2015050502","article-title":"Endothelial dysfunction: the secret agent driving kidney disease","volume":"27","author":"Johnson","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.dsx.2018.11.058_bib27","first-page":"8420768","article-title":"Circulating endothelial microparticles and correlation of serum 1,25-dihydroxyvitamin D with adiponectin, nonesterified fatty acids, and glycerol from middle-aged men in China","author":"Wan","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.dsx.2018.11.058_bib28","first-page":"250476","article-title":"Circulating endothelial microparticles in diabetes mellitus","author":"Tramontano","year":"2010","journal-title":"Mediat Inflamm"},{"issue":"8","key":"10.1016\/j.dsx.2018.11.058_bib29","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s40618-015-0273-z","article-title":"Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus","volume":"38","author":"Berezin","year":"2015","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.dsx.2018.11.058_bib30","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/2047487312445001","article-title":"Endothelial microparticles: missing link in endothelial dysfunction?","volume":"20","author":"Yong","year":"2013","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"10.1016\/j.dsx.2018.11.058_bib31","doi-asserted-by":"crossref","first-page":"e0119665","DOI":"10.1371\/journal.pone.0119665","article-title":"High soluble endoglin levels do not induce endothelial dysfunction in mouse aorta","volume":"10","author":"Nemeckova","year":"2015","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.dsx.2018.11.058_bib32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4274\/jcrpe.2906","article-title":"Soluble endoglin level increase occurs prior to development of subclinical structural vascular alterations in diabetic adolescents","volume":"8","author":"Emeksiz","year":"2016","journal-title":"J\u00a0Clin Res Pediatr Endocrinol"},{"issue":"1","key":"10.1016\/j.dsx.2018.11.058_bib33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1741-7015-8-86","article-title":"Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients","volume":"8","author":"Bl\u00e1zquez-Medela","year":"2010","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.dsx.2018.11.058_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.atherosclerosis.2012.03.001","article-title":"The role of endoglin in atherosclerosis","volume":"224","author":"Nachtigal","year":"2012","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.dsx.2018.11.058_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00592-014-0670-3","article-title":"Oscillating glucose and constant high glucose induce endoglin expression in endothelial cells: the role of oxidative stress","volume":"52","author":"La Sala","year":"2015","journal-title":"Acta Diabetol"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118305071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402118305071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T20:28:00Z","timestamp":1605558480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402118305071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S1871402118305071"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2018.11.058","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma endoglin in Type2 diabetic patients with nephropathy","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2018.11.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}